Terns Pharmaceuticals (TERN) Research & Development: 2020-2024
Historic Research & Development for Terns Pharmaceuticals (TERN) over the last 5 years, with Dec 2024 value amounting to $70.1 million.
- Terns Pharmaceuticals' Research & Development rose 12.64% to $10.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $39.6 million, marking a year-over-year increase of 26.53%. This contributed to the annual value of $70.1 million for FY2024, which is 10.42% up from last year.
- Terns Pharmaceuticals' Research & Development amounted to $70.1 million in FY2024, which was up 10.42% from $63.5 million recorded in FY2023.
- In the past 5 years, Terns Pharmaceuticals' Research & Development registered a high of $70.1 million during FY2024, and its lowest value of $28.0 million during FY2020.
- In the last 3 years, Terns Pharmaceuticals' Research & Development had a median value of $63.5 million in 2023 and averaged $57.7 million.
- Data for Terns Pharmaceuticals' Research & Development shows a peak YoY spiked of 60.28% (in 2023) over the last 5 years.
- Yearly analysis of 5 years shows Terns Pharmaceuticals' Research & Development stood at $28.0 million in 2020, then rose by 11.71% to $31.3 million in 2021, then climbed by 26.53% to $39.6 million in 2022, then surged by 60.28% to $63.5 million in 2023, then grew by 10.42% to $70.1 million in 2024.